News - Page 3 of 6 - Bách Quang

Reviscon Mono 2% – a one time injectable solution for osteoarthritis pain and mobility issues

VSY Biotechnology announced Health Canada’s approval of Reviscon Mono 2% (2.4 ml), a one-time injectable solution for osteoarthritis pain and mobility issues. VSY Biotechnology GmbH is pleased to announce that Health Canada has approved Reviscon Mono 2% (2.4 ml), a single-injection viscoelastic sodium hyaluronate solution designed to prevent pain and motion limitation associated with osteoarthritis in […]

FOX IV 810: The next generation of portable Diode Lasers from A.R.C. LASER

µCPC treatment – a gentle procedure for the treatment of open-angle glaucoma

Chatbot accuracy in ophthalmology: A work in progress

[06/09 – 10/09/2024] the 42nd Congress of the ESCRS will take place at Fira de Barcelona (Gran Via), Spain

[30/05 – 01/06/2024] The 36th APACRS Annual Meeting

[FEBRUARY 22-25] APAO 2024 – the 39th Asia-Pacific Academy of Ophthalmology (APAO) Congress

Vietnam Ophthalmology Conference was successfully held from October 13-15, 2023

[September 9] The new class in EDOF IOL segment by VSY Biotechnology in ESCRS 2023

VSY Biotechnology’s In-House 100% Glistening-Free IOL Material Redefines The IOL Market

The iStent®️ technology and How It Fits with The Unique Needs of Asian Eyes